Skip to main content
Journal cover image

A phase I trial of imatinib (GLEEVEC), hydroxyurea and RAD001 for patients with recurrent malignant glioma

Publication ,  Conference
Desjardins, A; Quinn, JA; Rich, JN; Vredenburgh, JJ; Sathornsumetee, S; Gururangan, S; Friedman, AH; Berg, W; Egorin, MJ; Salvado, A ...
Published in: NEURO-ONCOLOGY
October 1, 2006

Duke Scholars

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

October 1, 2006

Volume

8

Issue

4

Start / End Page

441 / 441

Location

Vienna, AUSTRIA

Publisher

DUKE UNIV PRESS

Conference Name

7th Congress of the European-Association-for-Neuro-Oncology (EANO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Desjardins, A., Quinn, J. A., Rich, J. N., Vredenburgh, J. J., Sathornsumetee, S., Gururangan, S., … Reardon, D. A. (2006). A phase I trial of imatinib (GLEEVEC), hydroxyurea and RAD001 for patients with recurrent malignant glioma. In NEURO-ONCOLOGY (Vol. 8, pp. 441–441). Vienna, AUSTRIA: DUKE UNIV PRESS.
Desjardins, A., J. A. Quinn, J. N. Rich, J. J. Vredenburgh, S. Sathornsumetee, S. Gururangan, A. H. Friedman, et al. “A phase I trial of imatinib (GLEEVEC), hydroxyurea and RAD001 for patients with recurrent malignant glioma.” In NEURO-ONCOLOGY, 8:441–441. DUKE UNIV PRESS, 2006.
Desjardins A, Quinn JA, Rich JN, Vredenburgh JJ, Sathornsumetee S, Gururangan S, et al. A phase I trial of imatinib (GLEEVEC), hydroxyurea and RAD001 for patients with recurrent malignant glioma. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2006. p. 441–441.
Desjardins, A., et al. “A phase I trial of imatinib (GLEEVEC), hydroxyurea and RAD001 for patients with recurrent malignant glioma.” NEURO-ONCOLOGY, vol. 8, no. 4, DUKE UNIV PRESS, 2006, pp. 441–441.
Desjardins A, Quinn JA, Rich JN, Vredenburgh JJ, Sathornsumetee S, Gururangan S, Friedman AH, Berg W, Egorin MJ, Salvado A, Friedman HS, Reardon DA. A phase I trial of imatinib (GLEEVEC), hydroxyurea and RAD001 for patients with recurrent malignant glioma. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2006. p. 441–441.
Journal cover image

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

October 1, 2006

Volume

8

Issue

4

Start / End Page

441 / 441

Location

Vienna, AUSTRIA

Publisher

DUKE UNIV PRESS

Conference Name

7th Congress of the European-Association-for-Neuro-Oncology (EANO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences